> Thermo Fisher Scientific ($TMO) said it will fast-track 12 research teams' gene-expression profiling projects focused on biomarker discovery by way of a new grant program. Release
> Arizona's Global Cancer Diagnostics is launching a $99 diagnostic test designed to enable the early detection of lung cancer. Release
> Illumina ($ILMN) will partner with genetic screening and diagnostics company Reprogenetics on in vitro fertilization gene-sequencing/diagnostics development. Story
> Tymora Analytical Operations in Indiana is moving ahead with a new federal grant to study blood plasma for biomarkers that can be a sign of various diseases. Story
> Massachusetts' Metamark has rolled out ProMark, a new protein-based biopsy test designed to give a more accurate prognosis for men diagnosed with prostate cancer. Release